Similar articles

• Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.

  Kahan BD, Gibbons S, Tejpal N, Chou TC, Stepkowski S. Kahan BD, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1090-1. Transplant Proc. 1991. PMID: 1824888 No abstract available.
• The effect of long-term cyclosporine therapy on natural killer cell activity.

  Versluis DJ, Metselaar HJ, Bijma AM, Vaessen LM, Wenting GJ, Weimar W. Versluis DJ, et al. Transplant Proc. 1988 Apr;20(2 Suppl 2):179-85. Transplant Proc. 1988. PMID: 3129839 No abstract available.
• Cloning of human CD3+ T cells and CD3- natural killer cells and requirements for long-term expansion.

  van de Griend RJ, Goedegebuure SP, van Krimpen BA, Bolhuis RL. van de Griend RJ, et al. Transplant Proc. 1988 Apr;20(2):149-54. Transplant Proc. 1988. PMID: 2966464 No abstract available.
• Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.

  Hess AD, Esa AH, Colombani PM. Hess AD, et al. Transplant Proc. 1988 Apr;20(2 Suppl 2):29-40. Transplant Proc. 1988. PMID: 2834840 Review. No abstract available.
• Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.

  Weir MR. Weir MR. Am J Med. 1991 May 17;90(5A):32S-36S. doi: 10.1016/0002-9343(91)90483-e. Am J Med. 1991. PMID: 2039018 Review.